ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VNDA Vanda Pharmaceuticals Inc

6.15
-0.12 (-1.91%)
After Hours
Last Updated: 16:28:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,013,623
Bid Price 6.13
Ask Price 6.22
News -
Day High 6.43

Low
3.295

52 Week Range

High
6.76

Day Low 6.09
Share Name Share Symbol Market Stock Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.12 -1.91% 6.15 16:28:00
Open Price Low Price High Price Close Price Previous Close
6.23 6.09 6.43 6.12 6.27
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
11,900 2,013,623 US$ 6.25 US$ 12,583,799 - 3.295 - 6.76
Last Trade Type Quantity Price Currency
16:28:00 formt 200 US$ 6.15 USD

Vanda Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
350.98M 57.54M - 192.64M 2.51M 0.04 139.91
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vanda Pharmaceuticals News

Date Time Source News Article
6/06/202415:30Edgar (US Regulatory)Form 8-K - Current report
6/06/202408:24PR Newswire (US)Vanda Pharmaceuticals Confirms Receipt of Unsolicited,..
5/30/202416:20PR Newswire (US)Vanda Pharmaceuticals Announces Participation in the..
5/30/202415:48PR Newswire (US)Vanda Pharmaceuticals Announces Completion of Transfer of..
5/29/202413:17PR Newswire (US)Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
5/24/202415:49Edgar (US Regulatory)Form 8-K - Current report
5/24/202415:46PR Newswire (US)Vanda Pharmaceuticals Board of Directors Determines that..
5/24/202415:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/24/202415:31Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]
5/21/202415:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VNDA Message Board. Create One! See More Posts on VNDA Message Board See More Message Board Posts

Historical VNDA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.056.55874.926.002,524,6711.1021.78%
1 Month5.006.55874.865.601,290,2401.1523.00%
3 Months3.796.55873.715.042,626,1332.3662.27%
6 Months4.316.55873.464.731,756,2771.8442.69%
1 Year6.266.763.2954.771,364,307-0.11-1.76%
3 Years18.0521.86273.2957.68795,507-11.90-65.93%
5 Years13.5721.86273.2959.54710,755-7.42-54.68%

Vanda Pharmaceuticals Description

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.

Your Recent History

Delayed Upgrade Clock